MLP Group S.A. (WSE:MLG)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,920	1,632	1,704	1,624	1,684	1,637
Market Cap Growth	14.21%	-4.23%	4.88%	-3.55%	2.90%	68.90%
Enterprise Value	4,407	3,761	3,486	3,354	2,928	2,654
Last Close Price	80.00	68.00	71.00	76.00	78.80	83.00
PE Ratio	6.13	4.38	-	3.85	3.51	9.61
PS Ratio	4.98	4.38	4.72	5.82	8.40	8.53
PB Ratio	0.71	0.59	0.71	0.65	0.92	1.35
P/OCF Ratio	16.44	17.70	9.63	9.87	10.22	17.65
EV/Sales Ratio	11.44	10.10	9.66	12.02	14.60	13.83
EV/EBITDA Ratio	22.82	20.27	19.51	24.81	31.82	31.06
EV/EBIT Ratio	23.11	20.48	19.58	24.89	31.88	31.32
Debt / Equity Ratio	1.08	1.13	0.91	0.76	0.84	1.01
Debt / EBITDA Ratio	15.12	16.76	12.16	14.04	16.73	14.27
Asset Turnover	0.07	0.06	0.07	0.06	0.06	0.08
Inventory Turnover	-	-	22.70	9.81	-	-
Quick Ratio	3.03	2.24	1.20	1.45	1.01	2.03
Current Ratio	3.04	2.24	1.20	1.50	1.08	2.73
Return on Equity (ROE)	12.27%	14.48%	-2.13%	19.54%	31.65%	15.85%
Return on Assets (ROA)	2.10%	1.99%	2.21%	1.92%	1.77%	2.23%
Return on Capital (ROIC)	2.32%	2.20%	2.48%	2.17%	1.98%	2.50%
Earnings Yield	16.32%	22.81%	-3.06%	26.00%	28.53%	10.41%
Buyback Yield / Dilution	-	-	-11.85%	-3.74%	-13.46%	-0.62%
Total Shareholder Return	-	-	-11.85%	-3.74%	-13.46%	-0.62%

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.